•
Dec 31, 2020

DaVita Q4 2020 Earnings Report

DaVita's financial performance was impacted by COVID-19 challenges, but the company continued to provide life-sustaining care to patients.

Key Takeaways

DaVita Inc. reported consolidated revenues of $2.905 billion for Q4 2020. Diluted earnings per share from continuing operations was $1.67, impacted by COVID-19 challenges. The company repurchased 4,193,401 shares for $417 million during the quarter.

Consolidated revenues reached $2.905 billion.

Operating income was $382 million, with a 13.1% operating margin.

Diluted earnings per share from continuing operations was $1.67.

The company repurchased 4,193,401 shares for $417 million.

Total Revenue
$2.91B
Previous year: $2.9B
+0.2%
EPS
$1.67
Previous year: $1.86
-10.2%
US Dialysis Treatments
7.57M
Previous year: 7.68M
-1.4%
US Avg Treatments per day
95.88K
Previous year: 96.74K
-0.9%
US Dialysis Treatment Days
79
Previous year: 79.4
-0.5%
Gross Profit
$848M
Previous year: $898M
-5.5%
Cash and Equivalents
$325M
Previous year: $1.1B
-70.5%
Free Cash Flow
$210M
Previous year: $415M
-49.4%
Total Assets
$17B
Previous year: $17.3B
-1.9%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita provided its 2021 guidance with adjusted operating income between $1.675 billion and $1.825 billion, adjusted diluted net income per share between $7.75 and $8.75, and free cash flow between $900 million and $1.150 billion.

Revenue & Expenses

Visualization of income flow from segment revenue to net income